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Initial testing of a pixelated silicon detector prototype in proton therapy
Abstract
As technology continues to develop, external beam radiation therapy is being employed, with increased
conformity, to treat smaller targets. As this occurs, the dosimetry methods and tools employed to
quantify these fields for treatment also have to evolve to provide increased spatial resolution. The team at
the University of Wollongong has developed a pixelated silicon detector prototype known as the dose
magnifying glass (DMG) for real-time small-field metrology. This device has been tested in photon fields
and IMRT. The purpose of this work was to conduct the initial performance tests with proton radiation,
using beam energies and modulations typically associated with proton radiosurgery. Depth dose and
lateral beam profiles were measured and compared with those collected using a PTW parallel-plate
ionization chamber, a PTW proton-specific dosimetry diode, EBT3 Gafchromic film, and Monte Carlo
simulations. Measurements of the depth dose profile yielded good agreement when compared with
Monte Carlo, diode and ionization chamber. Bragg peak location was measured accurately by the DMG by
scanning along the depth dose profile, and the relative response of the DMG at the center of modulation
was within 2.5% of that for the PTW dosimetry diode for all energy and modulation combinations tested.
Real-time beam profile measurements of a 5 mm 127 MeV proton beam also yielded FWHM and FW90
within ±1 channel (0.1 mm) of the Monte Carlo and EBT3 film data across all depths tested. The DMG
tested here proved to be a useful device at measuring depth dose profiles in proton therapy with a stable
response across the entire proton spread-out Bragg peak. In addition, the linear array of small sensitive
volumes allowed for accurate point and high spatial resolution one-dimensional profile measurements of
small radiation fields in real time to be completed with minimal impact from partial volume averaging.
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RADIATION MEASUREMENTS

Initial testing of a pixelated silicon detector prototype in
proton therapy
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Abstract
As technology continues to develop, external beam radiation therapy is being
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employed, with increased conformity, to treat smaller targets. As this occurs, the
dosimetry methods and tools employed to quantify these ﬁelds for treatment also
have to evolve to provide increased spatial resolution. The team at the University of
Wollongong has developed a pixelated silicon detector prototype known as the
dose magnifying glass (DMG) for real-time small-ﬁeld metrology. This device has
been tested in photon ﬁelds and IMRT. The purpose of this work was to conduct
the initial performance tests with proton radiation, using beam energies and modulations typically associated with proton radiosurgery. Depth dose and lateral beam
proﬁles were measured and compared with those collected using a PTW parallelplate ionization chamber, a PTW proton-speciﬁc dosimetry diode, EBT3 Gafchromic
ﬁlm, and Monte Carlo simulations. Measurements of the depth dose proﬁle yielded
good agreement when compared with Monte Carlo, diode and ionization chamber.
Bragg peak location was measured accurately by the DMG by scanning along the
depth dose proﬁle, and the relative response of the DMG at the center of modulation was within 2.5% of that for the PTW dosimetry diode for all energy and modulation combinations tested. Real-time beam proﬁle measurements of a 5 mm
127 MeV proton beam also yielded FWHM and FW90 within 1 channel (0.1 mm)
of the Monte Carlo and EBT3 ﬁlm data across all depths tested. The DMG tested
here proved to be a useful device at measuring depth dose proﬁles in proton therapy with a stable response across the entire proton spread-out Bragg peak. In addition, the linear array of small sensitive volumes allowed for accurate point and high
spatial resolution one-dimensional proﬁle measurements of small radiation ﬁelds in
real time to be completed with minimal impact from partial volume averaging.
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1 | INTRODUCTION
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radiotherapy,13–15 it had yet to be tested in proton therapy. Accordingly, the uniformity of response across the proton spread-out Bragg

As imaging techniques continue to evolve, the targets being pre-

peak (SOBP) was unclear.

sented for treatment in our clinical practice are becoming smaller in

The goal of this work was to evaluate a DMG prototype in pro-

size, oftentimes requiring beams of less than 1.0 cm in diameter for

ton ﬁelds typically associated with radiosurgical applications at Loma

treatment. This technical challenge is compounded by expanding

Linda University Medical Center (LLUMC). The response of the

treatment sites, including functional radiosurgery, which demand that

device was compared to a commercially available PTW proton diode,

small beams be delivered with high precision to high doses. These

a PTW plane-parallel ionization chamber, and Gafchromic EBT3 ﬁlm.

small beam sizes require alternative dosimetry methods including

Additionally, an in-house developed and validated Geant4-based

diodes,1,2 micro-ion chambers,3,4 and ﬁlm5,6 for measuring beam out-

Monte Carlo application was used for comparison. Both depth dose

put, as standard radiotherapy ion chamber devices exhibit partial vol-

and lateral proﬁles were evaluated. It was hypothesized that these

ume averaging due to their relatively large sensitive volume (SV)

tests would not only evaluate the DMG against established forms of

size. Protons have the added complication that their Linear Energy

metrology, but also identify future directions for development.

Transfer or LET varies as a function of depth (or energy), which can
signiﬁcantly impact detector response. Proton beam scanning and
intensity-modulated proton therapy (IMPT) is another area where

2 | METHODS

accurate and efﬁcient methods for real-time measurements with high
spatial resolution are necessary. In the case of proton beam scan-

The DMG is an array of 128 n+-strips of 2 mm length and 20 lm

ning, not only is an understanding of the machine output at a speci-

width on a p-type silicon substrate 380 lm thick. The pitch (or SV

ﬁc point essential to accurate dose delivery, but accurate beam

center-to-center separation) is 100 lm with a p-stop implantation

proﬁle information at various depths in water is also critical for accu-

between the microstrips (80 lm) for compensation of the accumula-

rate treatment planning and reproducible beam delivery.

tion layer generated by irradiation of the thick silicon dioxide.13–15

For small-ﬁeld and beam proﬁle measurements, radiochromic ﬁlm

A schematic of the DMG SV array is displayed in Fig. 1. The assem-

has often been seen as the standard metrology device, providing high

bly was pre-irradiated to a dose of 4 MRad with Co-60 before

spatial resolution for such applications. However, in the case of pro-

deployment for testing.

ton therapy, radiochromic ﬁlm can exhibit a varying response to

The DMG is glued and wire bonded onto a 400 lm thick kapton

changing LET.6 Additionally, radiochromic ﬁlm also exhibits a number

carrier to provide the proper fan out of the signal for connecting the

of technical and ease-of-use limitations that can limit its deployment

readout electronics and minimize the impact of these connections on

in regular clinical QA programs. Chief of these is that postexposure

the proton scatter conditions. The detector is used in passive mode

processing limits radiochromic ﬁlm’s ability to provide real-time data.7

(no bias applied at the contacts) and readout is carried out with the

In addition, artifacts can be introduced in dose measurements due to

detector conﬁgured as a planar detector with a common electrode

properties of the ﬁlm itself (e.g., variations in active layer or substrate

p+ from the same side as the n+ strips. For this work, the DMG was

thickness, postexposure intensiﬁcation), environmental and handling

mounted to a Lucite probe holder (Fig. 2) for rigidity and to facilitate

effects (e.g., temperature, light sensitivity), and scanner response (e.g.,

mounting in a water tank; however, the compact nature of the

lateral position artifact,8 ﬁlm orientation,9 dust, ﬁngerprints, ﬁlm curl,
and local-, inter- and intrascanner factors).7 Finally, inter- and intraﬁlm lot and scanner variation can result in inconsistent dose mapping
between ﬁlm lots, scanner models, and environmental processing
conditions.10 Recent improvements in technology and techniques,
such as multiple-channel dosimetry,11 simpliﬁed calibration and intralot recalibration,10 calibration-less relative dosimetry,12 and ﬁlm that
is less sensitive to light have signiﬁcantly mitigated these concerns.
They have not, however, eliminated them entirely.
In an effort to identify more efﬁcient and real-time methods of
small-ﬁeld dosimetry, the team at the Center for Medical Radiation
Physics (CMRP) at the University of Wollongong have continued
solid-state development of small pixelated arrays of monolithic silicon diode detectors. The prototype device tested in this work is
referred to as the dose magnifying glass (DMG). It is a pixelated silicon detector that has the potential to provide not only point dose
measurements with a high degree of spatial resolution, but also
beam proﬁle measurements in real time. However, while this device
has been tested in photon therapy, IMRT, and stereotactic

F I G . 1 . Schematic of two n+ SV elements in the DMG detector.
Note the entire DMG is comprised of 128 SV elements.
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the CPU computation load of the host computer to minimize the
USB latency, which varies between 2 and 3 ms. Data losses are
avoided through the use of a dual, cascade FIFO buffer stage of 17
Kbyte of RAM.
Testing of the DMG prototype was conducted in the Gantry 1
treatment room at LLUMC. This treatment room is ﬁtted with a
6-degree-of-freedom robotic patient positioner and associated 2D
orthogonal imaging system17 to aid in alignment of the patient and,
in this case, the experimental setup (Fig. 4). Depth dose and lateral
beam proﬁles were measured for our standard radiosurgery energies of 127 MeV (90% dose range in water of 9.88 cm) and
157 MeV (90% dose range in water of 15.15 cm) through a singlestage scattering system. The single-stage scattering system provides a maximum ﬁeld size of 4 cm diameter with collimation provided via a dedicated radiosurgery cone that attaches to the end of
the proton nozzle.18 This system allows for minimal air gap
between the collimator and the patient, ensuring that the proton
penumbra is minimized while maintaining a high dose rate. Field
sizes measured and presented here were 0.5 and 2.0 cm in diameF I G . 2 . Images of the DMG probe used in this work. The minimal
thickness (lower left) allows for a wide range of mounting options
and minimal perturbation of the proton beam while the linear array
(lower right) allows for concurrent point dose and beam proﬁle
measurements.

ter, created by brass inserts 7.5 cm in thickness along the beam
axis. An array of beam modulations were tested that are typical for
radiosurgical applications, including an unmodulated case that is
representative of what can be used in functional radiosurgery or
proton beam scanning treatments.
Depth dose and lateral proﬁles were measured in a water tank

device allows for a wide range of mounting options, including within

measuring 250 mm 9 250 mm 9 500 mm with a 180 mm diameter

specialized phantoms and probes.

Lexan window 6 mm thick at the upstream surface. Detector motion

Figure 3 shows the schematic block diagram of the DMG data

was facilitated by a linear corkscrew rail and stepper motor, which

acquisition system. The FPGA motherboard houses a Xilinx

can be orientated either parallel or perpendicular to the beams central

XC3S400 along with a Cypress USB interface to establish the com-

axis. The stepper motor is controlled with a single-axis programmable

munication with the host computer. The motherboard drives the dig-

controller and micro-step driver with USB 2.0/RS-485/Modbus-RTU

ital interface of the TERA06 board, a dual 64 channel preampliﬁer.

communication, and user interface is achieved via custom designed

The two TERA06 chips read out the 128 detector channels simulta-

LabVIEW 2011 software (National Instruments Corporation, Austin

neously.16 Each channel of the TERA06 is a charge-to-frequency

TX, USA). The DMG was waterproofed for this work through the use

converter equipped with a 16-bit counter that records the number

of a custom plastic cover, which also served to make the device light

of times the input charge (accumulated into a capacitor during the

proof. For comparison with the DMG, depth dose information for the

integration time) exceeds the quantum charge, settable by an analog

2 cm diameter beam was also collected with a PTW PR60020 proton

potentiometer. A digital reset is used for zeroing the counter values

diode and a PTW Markus N23343 plane-parallel ion chamber. These

immediately after each frame is acquired. A graphical user interface

detectors were selected as the PTW PR60020’s stability of perfor-

(GUI) has been custom designed at the CMRP and provides the

mance in proton therapy has been demonstrated previously,1 while

operator with all the controls to acquire the data from the detector

the PTW Markus has been in continued clinical use at our facility for

in real time and also perform preprocessing of the raw binary data.

over 25 years. The PTW Markus N23343 is a plane-parallel ionization

The GUI is compiled under the C++ developer suite Nokia QT

chamber with a SV of 0.055 cm3 vented to air and a 0.03 mm poly-

rev4.0. It manages the USB link using dynamic language libraries

ethylene entrance window. The device was used with a water-equiva-

(DLL) speciﬁcally developed for the USB Cypress interface. It initial-

lent and water-proof protective cap of 1.06 mm for measurements in

izes the COM-link, sends the ﬁrmware to the FPGA, and acknowl-

water. The PTW PR60020 proton diode has a single cylindrical SV

edges if the device is connected and fully operational. The operator

with a cross-sectional area of 1 mm2 and a thickness of 20 lm,

controls the acquisition settings and the relevant parameters such as

located behind a 1.33 mm water-equivalent window.

the integration time, the total acquisition time, and all the comple-

For beam proﬁle measurements using Gafchromic ﬁlm, 9 9 5 cm

mentary signals necessary for the operation of each TERA06 chip.

pieces of Gafchromic EBT3 ﬁlm (Advanced Materials Group, Wayne,

The motherboard stores the data into an internal FIFO (First-In First-

NJ, USA) were placed in custom designed holders and positioned at

Out) and triggers the GUI to download the data in burst-mode.

a speciﬁed depth within a water tank. Films were irradiated using

The size of the burst can be user-deﬁned and optimized based on

unmodulated beams at the same energies (i.e., 127 and 157 MeV),
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DMG data acquisition architecture.

dosimetry method based on a rational function-ﬁt to previously
exposed calibration ﬁlms.11 Cross-sectional proﬁles of the dose maps
were obtained using Film QA Pro. Data were normalized based on
the maximum dose value.
At LLUMC, protons are accelerated by a synchrotron and delivered to treatment rooms in 2.2 s pulses. Thus, the DMG records
signal from impinging protons separated by time intervals where
the device is in a quiescent state. Therefore, before analysis, quiescent background time points were separated from data time
points and the average background signal was subtracted from
each data time point. Depth dose proﬁles were determined using
channels 85–115 (which corresponds to a 3.1 mm width of sensitive area perpendicular to the beam) and normalized to data measured by the DMG at the shallowest WED for each experimental
case (i.e., 48, 50, or 68 mm WED). Two additional steps were
applied when processing transverse proﬁle data: a calibration step
and removal of over/under-responsive channels. Calibration factors
for each channel were calculated for each energy (i.e., 127 and
157 MeV) at the level of the unmodulated Bragg peak for a 2 cm
diameter proton ﬁeld. Because the 2 cm beams have a ﬂat proﬁle
over the lateral extent of the DMG, all channels were normalized
to the same constant signal and the corresponding calibration factors were applied to each channel. Certain channels in the prototype device did not produce a signal, or were excessively over/
under-responsive. These later channels (so designated if the absolute value of their signal had a percent difference greater than
50% when compared to the average of four neighboring nonzero
channels) were replaced with zero signal. Transverse dose proﬁles
were normalized with respect to the proﬁle centroid.
Monte Carlo simulations provided further comparative data for
F I G . 4 . DMG experimental setup for depth dose and beam proﬁle
measurements with a magniﬁed view (bottom). Note the extended
X-ray imager (top) which is used to ensure detector alignment and
parallel travel with the beam central axis.

both depth dose and lateral proﬁles. These simulations were performed using software developed in-house that incorporates the
Geant4 toolkit.19,20 Protons and secondary particles were tracked
through a model of our Gantry 1 treatment nozzle21,22 using a
custom physics list incorporating: low energy Livermore physics

water-equivalent depths (WED), and treatment nozzle conﬁgurations

models for electromagnetic interactions, binary cascade models of

as analogous DMG and MC data. Irradiation duration for ﬁlm mea-

inelastic interactions of hadrons and heavy ions, and the high-pre-

surements was ~3 or ~3.33 min for 127 and 157 MeV, respectively.

cision neutron package.23 The treatment nozzle conﬁguration and

Films were scanned in 48 bit RGB format at 72 dpi using an Epson

proton energies were chosen to mimic the experimental conditions

10000XL ﬂatbed scanner. Dose maps were created with Film QA

described above (Fig. 5). In particular, simulated 127 or 157 MeV

Pro software (Ashland Inc., Wayne, NJ, USA) using a triple-channel

protons were delivered through a single-stage scattering system to

WROE
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F I G . 5 . Schematic diagram of the simulated geometry of the Gantry 1 treatment nozzle with radiosurgery cone geometry used in Geant4
Monte Carlo simulations. The components are: the secondary emission monitor (SEM) and titanium exit window, multiwire ion chamber
(MWIC), initial scatterer (two lead wedges) (S1), ﬁrst proton transmission ionization chamber (pTIC1), ﬁrst steel ﬁxed aperture (FA1), second
pTIC2, second ﬁxed aperture (FA2), Perspex modulation wheel, third ﬁxed aperture (FA3), multielement transmission ion chamber (MTIC), brass
precollimator (PCOL), precollimator and ridge ﬁlter (RFIL), radiosurgery cone (RSC), and water phantom.

a voxelized water phantom. The beams were either unmodulated,

single array of SV’s which all individually contribute charge-to-detec-

or modulated to 15, 30 or 60 mm. Total dose was scored in each

tor response at a given location. The number of SV’s analyzed is cus-

voxel, and depth dose and transverse proﬁles were calculated

tomizable and provides the user greatest ﬂexibility with selecting a

using software developed in Python. Depth dose proﬁles for

total SV size suitable for the ﬁeld size under study. This later mode

20 mm

was chosen to evaluate the DMG performance in measuring the

diameter

beams

were

determined

using

voxels

of

1.0 9 1.0 9 1.0 mm, phantom range cuts of 250 lm, and 1.3 bil-

depth dose proﬁles of a passively scattered proton beam (Figs. 6

lion particle histories per simulation. Modulated depth proﬁles

and 7). Thirty DMG SV elements were used at each measurement

were normalized with respect to dose at the center of modulation

depth (corresponding to a total SV length of 3.1 mm perpendicular

(COM) of the spread-out Bragg peak, and unmodulated depth

to the beam) of a 127 MeV or 157 MeV 20 mm diameter proton

dose proﬁles were normalized by maximum dose. Depth dose pro-

beam, for comparison with a commercial PTW diode, PTW Markus

ﬁles were determined using the central array of 2 9 2 9 1 voxels

parallel-plate ionization chamber and Monte Carlo.

of

For unmodulated proton beams, the proximal edge of the Bragg

2 9 2 9 1 mm3 for depth dose analysis). Transverse dose proﬁles

peak and the peak location was measured accurately by the DMG.

of 5 mm diameter beams were determined using voxels of the

Modulated data measured by the DMG exhibited good agreement to

same size as the active element of the DMG (X 9 Y 9 Z dimen-

the PTW diode and Markus chamber, especially across the SOBP.

sions of 0.02 9 2.0 9 0.38 mm with a center-to-center element

Across the plateau region of the SOBP, the DMG exhibited an aver-

spacing of 0.1 mm) with range cuts of 100 lm and 5.1 billion his-

age response within 1% of the PTW diode, for all cases studied

tories. Transverse proﬁles were normalized with respect to maxi-

except 157 MeV with a 60 mm modulation. For the 157 MeV

mum dose.

60 mm modulation case, the shape of the SOBP was well repre-

column

of

voxels

(thus

presenting

a

sensitive

area

sented by the DMG, however the DMG did over-respond in the
SOBP region by an average of 3.3% when compared to the PTW

3 | RESULTS

proton diode and an average of 1.4% when compared with the PTW
Markus plane-parallel ion chamber.

The DMG can be operated as a simple dosimeter, with charge mea-

As all depth dose data were normalized at the depth of shallow-

sured over either a single SV or multiple SV’s across a given linear

est DMG measurement, analyzing the COM response of each detec-

displacement. The single SV option allows for point measurements

tor type relative to a commercially available small SV solid-state

of a high spatial resolution (2 mm long and 20 lm wide) to be made,

detector (PTW diode) with a demonstrated stability in proton

which is of signiﬁcant beneﬁt in very small or high-gradient radiation

therapy,1 provides an indication of detector stability in this variable

ﬁelds. The disadvantage of this mode of operation is that the small

LET region. These data, displayed in Table 1, demonstrated that the

SV requires longer acquisition times to accrue sufﬁcient statistics. It

relative response of the DMG at the COM was within 2.5% of a

is envisaged that the DMG would be operated more typically as a

PTW diode detector for all energy and modulation combinations

320
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FIG. 6.

Measured and simulated depth dose proﬁles for varying beam modulations in water for a 127 MeV, 20 mm diameter proton beam.

FIG. 7.

Measured and simulated depth dose proﬁles for varying beam modulations in water for a 157 MeV, 20 mm diameter proton beam.
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tested. Additionally, the DMG data do not show a decrease in

the number of suppressed channels increased to 14. While the addi-

response over the SOBP region and the shape of the SOBP com-

tional null channels for the 157 MeV case do impact the total data

pares well with the other detector modalities. Both of these features

acquired, it did not impact agreement of the overall beam proﬁle

indicate an LET independence of this device for clinical proton ther-

shape as the FWHM and FW90 were measured by the DMG to

apy energies, albeit additional measurements may be necessary with

within 2 channels (0.2 mm) of the Monte Carlo and EBT3 ﬁlm

discrete proton energies to validate this.

data for all depths tested.

In routine QA applications, it is expected that the DMG will be
operated using all SV elements to gain both point dose measurement data as well as beam proﬁle data. Data were collected for

4 | DISCUSSION

5 mm diameter, 127 and 157 MeV proton beams at various depths
along the depth dose proﬁle (Figs. 8 and 9). Excellent agreement in

The beam proﬁles measured with the DMG showed excellent agree-

proﬁle shape was observed for all measurement locations when

ment with Monte Carlo and Gafchromic ﬁlm data. The high spatial

compared with Monte Carlo and EBT3 ﬁlm data. Note that the edge

resolution of the device is comparable to that of ﬁlm and allows for

of the detector array is at a displacement of 1.6 mm and 1.7 mm

measurement of the smallest ﬁelds currently used in clinical proton

for the 127 MeV and 157 MeV cases respectively, so no data are

therapy (e.g., 5 mm diameter). Unlike ﬁlm, that requires postprocess-

available below these displacements. For 127 MeV, the FWHM and

ing and special handling, the DMG provides readout that is refreshed

FW90 reported by the DMG was within 1 channel (0.1 mm) of

in real time via a graphical user interface. The real-time nature of the

the Monte Carlo and EBT3 ﬁlm data across all depths tested. The

data acquisition is very useful, especially for proton pencil beam scan-

157 MeV data exhibited additional statistical uncertainty in the

ning applications, where efﬁcient real-time feedback to accelerator

measurement leading to the suppression of additional channels (see

staff is important during the acceptance testing and commissioning

Method) across the measured proﬁle. These suppressed channels

process. When comparing with other data sets or if further analysis is

are clearly visible as null channels in Figs. 8 and 9. Between dis-

required, the data can be output for graphing and analysis using any

placements of 2 mm and 11 mm, there was on average eight sup-

of the common computer-based tools for this purpose.

pressed channels for the 127 MeV case while for 157 MeV proﬁles

The DMG tested in this project is a prototype instrument and
certain reﬁnements are necessary prior to clinical deployment in pro-

T A B L E 1 Relative dose measured by each modality at the COM for
varying beam energy and modulation combinations. The difference
(as a percentage) of each modality is calculated relative to the
response of the PTW Diode and represented as a percentage
(Difference = 100 9 (Dx-Ddiode)/Ddiode).
Relative dose at COM

Difference
wrt PTW Diode (%)

ton therapy. Firstly, several channels were removed from analysis
because they either were unresponsive or produced excessively high
amounts of electronic noise that could not be corrected for. Such
channels may be caused by issues in the manufacturing process and
may be exacerbated by sensitive cabling and connections. The loss
of data can impact measured results and lead to the generation of
an incomplete data set, however, in this study the suppression of

127 MeV–15 mm modulation
DMG

1.720

0.175

PTW–Diode

1.717

–

PTW–Markus

1.725

0.446

Geant4

1.731

0.821

127 MeV–30 mm modulation

these channels in our prototype did not signiﬁcantly impact the
beam proﬁle agreement with either Monte Carlo or EBT3 ﬁlm. In
addition, for production DMG detectors, scanning laser systems such
as those used in high energy physics24 could be used to evaluate the
DMG systems prior to deployment allowing for selection of units
that have all of their SV elements operating within acceptable limits.

DMG

1.314

1.754

PTW–Diode

1.338

–

increased noise and statistical uncertainty, which can be traced to

Beam

proﬁle

measurements

for

157 MeV

protons

exhibited

PTW–Markus

1.355

1.268

the cabling system in this existing prototype. The aluminized ribbon

Geant4

1.333

0.353

cables between the DMG probe and the DAQ system proved to be

157 MeV–30 mm modulation

very delicate and underwent degradation as the experiments pro-

DMG

1.475

0.860

gressed. The ruggedness of this component will have to be

PTW–Diode

1.487

–

addressed as we move toward a clinical system.

PTW–Markus

1.504

1.114

When applying a detector system to scanned proton therapy,

3.857

the detector’s ability to handle high instantaneous dose rates needs

Geant4

1.545

to be considered. In this study, the DMG was tested in a pulsed pro-

157 MeV–60 mm modulation
DMG

1.233

2.465

PTW–Diode

1.203

–

PTW–Markus

1.222

1.581

Geant4

1.228

2.044

ton therapy environment provided by a synchrotron with a 0.4 s
pulse duration and a 2.2 s duty cycle.25 Average dose rates of up to
12 Gy/min, corresponding to an instantaneous dose rate of 66 Gy/
min, were tested with stable results. Above this value, some under
response of up to 10% was observed for average dose rates of
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F I G . 8 . Measured beam proﬁles at varying depths in water for a 127 MeV proton beam. Geant4 simulation data are also provided for
comparison. A simulated central beam axis depth dose proﬁle utilizing 0.25 9 0.25 9 0.25 mm3 voxels with DMG measurement locations
marked is provided for reference (top).

60 Gy/min. While these dose rates are rarely seen in passively deliv-

information in real time. The high spatial resolution and small SV size

ered clinical proton therapy applications, they can be encountered in

of the DMG does mean that data acquisition times are longer,

proton beam scanning applications. Additionally, as the trend of radi-

requiring 5–10 Gy per measurement to achieve adequate statistics.

ation treatment has been toward higher dose rates and faster treat-

However, extended data acquisition times for small SV detectors is a

ments, especially when applied to SRS and SBRT treatments, it can

suitable tradeoff given the spatial resolution enhancements they pro-

be foreseen that a uniform response at higher dose rates would fur-

vide. Further reduction of the SV size below 2000 lm in one dimen-

ther widen the clinical application of the DMG. An improvement in

sion would improve the spatial resolution of the device and reduce

this regard is already under investigation, as we believe that uniform

any impact of partial volume averaging for very small ﬁelds, although

response with dose rates exceeding 12 Gy/min (average) may be

this would be at the cost of data acquisition times.

achieved by reducing the integration time of the system. By doing

The size of the DMG array and the one-dimensional nature limit

so, it is hypothesized that counts will not be missed when the col-

the clinical applications to very small proton ﬁelds if beam proﬁle mea-

lected charge is too high (i.e., in a high dose-rate environment).

surements are required. Increasing the size of the array would widen

The

DMG

prototype

provided

a

small

linear

array

of

its application to larger passively scattered proton ﬁelds and also to

2000 lm 9 20 lm 9 380 lm SV’s for measurement of beam proﬁle

lower energies in proton pencil beam scanning applications, which typ-

data and dose with high spatial resolution. The ability to measure

ically have wider beam spots and longer low dose tails. The addition of

both parameters at a given depth or for a given experimental setup

either a second orthogonal array of SV’s or a complete 2D array of

in air is certainly more efﬁcient than using a scanned single volume

SV’s would also allow for concurrent measurement of point dose and

detector or ﬁlm which requires postprocessing and does not provide

orthogonal beam proﬁles (or the entire beam proﬁle in the case of a

WROE
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F I G . 9 . Measured and simulated beam proﬁles at varying depths in water for a 157 MeV proton beam. Geant4 simulation data are also
provided for comparison. A simulated central beam axis depth dose proﬁle utilizing 0.25 9 0.25 9 0.25 mm3 voxels with DMG measurement
locations marked is provided for reference (top).

2D array), which would provide further QA information in pencil beam

also for input to the treatment planning system (or validation of a

scanning applications where the size and shape of the proton beam

Monte Carlo system which generates data for the treatment planning

also need to be evaluated. The feasibility of this approach was recently

system).28 Such measurements are typically completed using radiochro-

demonstrated by the CMRP in development, characterization, and

mic ﬁlm and/or scanned ion chamber detectors;28,29 however, a pixe-

application of a 2D monolithic silicon pixel array (with submillimeter

lated silicon detector such as the DMG may provide a means for

26,27

SVs and a pitch of 2 mm) in dose mapping on a medical linac.

measuring these proﬁles in real time with greater efﬁciency as proﬁle

The DMG tested here has demonstrated that it can be used to pro-

data can be measured at each depth without the need for lateral detec-

vide real-time measurements of both point dose and beam proﬁles of

tor scanning. Additionally, for daily QA of pencil beam proton systems,

pencil proton beams with up to 0.02 mm resolution. Such resolution is

many centers use ion chamber arrays such as the I’mRT MatriXX (IBA

key in obtaining a precise picture of the sharp dose gradients when the

Dosimetry, Schwarzenbruck, Germany) which is comprised of a 2D

detector is properly orientated with the radiation ﬁeld. This informa-

array of 32 9 32 ion chambers with a center-to-center spacing of

tion, while very useful for collimated beams used in proton radiosurgery

7.6 mm and a SV size of 4 mm diameter and 5 mm height. The DMG

and functional radiosurgery, is also especially useful in pencil beam

may help augment these systems, especially if it can be developed as a

scanning applications for both commissioning and routine QA. During

nozzle-mounted 2D pixelated transmission sensor system.30 The

the commissioning process, the collection of accurate beam proﬁle data

improved spatial resolution of the DMG would allow for more accurate

as a function of depth in water for the complete clinical range of proton

daily analysis of the proton beam size and shape for evaluation of accel-

energies is essential for evaluation of system performance/stability and

erator/beam transport performance.
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5 | CONCLUSION
The DMG prototype tested here proved to be a useful device at
measuring depth dose proﬁles in proton therapy, with negligible variation in response across the clinical proton SOBP. In addition, the
small SV allowed for accurate point measurements of small radiation
ﬁelds to be completed without the partial volume averaging exhibited
by larger ion chamber detectors. The device’s high spatial resolution
and linear SV arrangement also allowed for beam proﬁles to be measured concurrently with depth dose measurements in real time. The
dual function of this device lends itself to QA measurements in
small-ﬁeld proton radiosurgery and also to beam commissioning in
proton beam scanning, where accurate and efﬁcient measurements
of the pencil beam proﬁles as a function of depth are of paramount
importance to intensity-modulated proton therapy treatment planning. The application of 2D silicon pixel transmission arrays based on
this technology, and already developed by the CMRP, could be the
next step in real-time QA and commissioning in proton therapy.
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